Posts with tag IP

Sort by Latest
Italy: Originator to pay over €13.4 million for abusing its dominant position by misusing the patent system
In this article we look at a ground-breaking decision of the Italian Supreme Court dealing with the compensation for damages caused by an abuse of dominant position through misusing the patent system. Summary In decision no. 9/2024 published on 2 January 2024, the Italian Civil Supreme Court confirmed that Pfizer has to pay over €13.4 million as compensation for damages to the Italian Health Ministry and Finance Ministry for having abused its dominant position in the prostaglandin drug market....
May 7, 2024
19 min read
First medicinal cannabis drug listed on the Australian...
On 1 May 2021 Epidyolex, the first medicinal cannabis drug product...
May 6, 2021
1 min read
Illumina v MGI: Patents Court gives guidance on the...
In Illumina v Latvia MGI Tech (MGI) [2021]...
March 26, 2021
9 min read
Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021
On the 3rd February 2021, the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021 (Bill) was introduced...
March 2, 2021
1 min read
Australian Courts apply “European Support” test to find key Wyeth’s Prevnar 13 patent invalid
In the recent decision in the Australian front of the Prevnar 13 patent litigation, Merck...
November 4, 2020
10 min read
The English Patents Court examines the law on enablement in the context of lack of novelty based on both prior publication and prior use.
Earlier this year (17 July 2019) in Takeda UK Limited v F. Hoffmann-La Roche AG Mr Justice Colin Birss...
November 19, 2019
5 min read